Peanut Allergy
📧 Sign up to get email alerts when something new happens for Peanut Allergy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-12Clinical Trial Results: Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts [Phase 2]
Phase 2 trial assessing remibrutinib for peanut allergy in adults, reporting efficacy, safety, and tolerability.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Basophil Activation Test (BAT) Sensitivity in Child Food Allergy [Phase 4]
A Phase 4 trial update reports on the sensitivity of the Basophil Activation Test in children with egg and peanut allergies; the study has b…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: PK/PD Study of IN-001 Sublingual Spray in Healthy Adults [Phase 1]
Phase 1 PK/PD study of IN-001 Sublingual Spray in healthy adults is currently recruiting to characterize pharmacokinetics and pharmacodynami…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study evaluating a peanut sublingual immunotherapy tablet for peanut allergy, sponsored by AL…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy [Phase 1, Phase 2]
The Pinpoint Trial evaluating prebiotics in peanut oral immunotherapy for peanut allergy has completed Phase 1/Phase 2 with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Accidental Reactions in Peanut/Tree Nut Allergic Children
A clinical trial studying accidental reactions in peanut and tree nut allergic children has completed. The sponsor is University Hospital, L…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety [NA]
This clinical trial compares high-dose versus low-dose oral peanut immunotherapy to assess efficacy and safety in individuals with peanut al…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IGNX001 [Phase 1]
This update reports the completion of a Phase 1 trial evaluating IGNX001 for peanut allergy, focusing on safety, tolerability, pharmacokinet…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Efficacy of Tezepelumab in Peanut Oral Immunotherapy [Phase 2]
Phase 2 trial evaluating tezepelumab for peanut oral immunotherapy is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Predicting Peanut Anaphylaxis and Reducing Epinephrine [NA]
This clinical trial update reports completion and posted results on predicting peanut-related anaphylaxis and reducing epinephrine use. The …
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children [Phase 3]
This clinical trial update reports the completion of a Phase 3 follow-up study (EPITOPE) assessing long-term efficacy and safety of DBV712 i…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Oral Immunotherapy for Young Children With Peanut Allergy - Small Children OIT [NA]
Clinical trial status update for Karolinska Institutet's peanut oral immunotherapy study in young children. The trial is currently active bu…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE) [Phase 2]
Phase 2 clinical trial (COMBINE) evaluating biologics to improve outcomes of oral immunotherapy for food and peanut allergies has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts [Phase 2]
A Phase 2 study evaluating the efficacy, safety and tolerability of remibrutinib in adults with peanut allergy has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: The Effect of Per Oral Immunotherapy in Severe Milk, Peanut and Egg Allergy in Adults [NA]
Completed clinical trial evaluating per oral immunotherapy for adults with severe milk, peanut, and egg allergy. Results posted in May 2025.
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy [Phase 2]
Phase 2 clinical trial update investigating the immune basis and clinical implications of threshold-based phenotypes in peanut allergy; resu…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008) [Phase 3]
This update reports longer-term results for AR101 in participants who previously enrolled in ARC008, providing insights from a Phase 3 peanu…
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age [Phase 3]
Phase 3 safety and efficacy study evaluating Viaskin Peanut in peanut-allergic children aged 1-3 years; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy [Phase 2]
A Phase 2 study evaluated abatacept as an adjuvant to peanut oral immunotherapy to promote remission in peanut allergy, and the trial has co…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine [Phase 1]
A completed Phase 1 study evaluated the safety, tolerability, and immune response of ASP0892 (ARA-LAMP-vax), a multivalent peanut DNA vaccin…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine [Phase 1]
A Phase 1 study evaluated safety, tolerability and immune response to ASP0892 (ARA-LAMP-vax), a multivalent DNA plasmid vaccine targeting pe…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy [Phase 3]
A Phase 3 trial evaluating ligelizumab (QGE031) for peanut allergy was terminated, with efficacy and safety results posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Boiled Peanut Oral Immunotherapy [Phase 1]
Results from a Phase 1 trial of Boiled Peanut Oral Immunotherapy for peanut allergy have been posted, indicating the study has completed enr…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Intervention to Reduce Early (Peanut) Allergy in Children [NA]
A completed clinical trial evaluating an intervention to prevent early peanut allergy in children with results posted in September 2024.
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants [Phase 3]
Phase 3 clinical trial results posted for omalizumab used as monotherapy and as adjunct to multi-allergen oral immunotherapy in peanut aller…